CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
110.85
1.28%
Market Trading Hours* (UTC) Opens on Monday at 08:00

Mon - Fri: 08:00 - 16:30

  • Summary
  • Historical Data
Trading сonditions
Spread 0.50
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.019349 %
Charges from full value of position ($-3.68)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.019349%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.002873 %
Charges from full value of position ($-0.55)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.002873%
Overnight fee time 22:00 (UTC)
Min traded quantity 0.1
Currency EUR
Margin 5.00%
Stock exchange France
Commission on trade 0%

Key Stats
Prev. Close 109.45
Open 109.25
1-Year Change 10.24%
Day's Range 109.25 - 110.95
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jan 17, 2025 110.85 3.10 2.88% 107.75 110.95 107.75
Jan 16, 2025 109.45 0.40 0.37% 109.05 109.85 108.15
Jan 15, 2025 109.75 2.00 1.86% 107.75 110.05 107.55
Jan 14, 2025 107.75 -1.50 -1.37% 109.25 109.25 107.65
Jan 13, 2025 110.15 1.20 1.10% 108.95 112.15 108.45
Jan 10, 2025 105.95 -0.10 -0.09% 106.05 107.75 105.15
Jan 9, 2025 106.75 2.00 1.91% 104.75 107.85 104.55
Jan 8, 2025 105.15 -0.30 -0.28% 105.45 107.65 103.85
Jan 7, 2025 107.25 2.50 2.39% 104.75 107.55 104.75
Jan 6, 2025 105.15 4.10 4.06% 101.05 105.55 101.05
Jan 3, 2025 101.55 -0.80 -0.78% 102.35 102.35 101.45
Jan 2, 2025 102.45 -0.70 -0.68% 103.15 103.75 101.05
Dec 31, 2024 103.15 2.30 2.28% 100.85 103.25 100.85
Dec 30, 2024 102.45 1.90 1.89% 100.55 102.95 100.55
Dec 27, 2024 102.05 0.50 0.49% 101.55 102.15 100.65
Dec 24, 2024 102.05 0.80 0.79% 101.25 102.55 101.15
Dec 23, 2024 100.95 0.30 0.30% 100.65 102.05 100.65
Dec 20, 2024 101.95 1.10 1.09% 100.85 101.95 100.35
Dec 19, 2024 101.05 1.00 1.00% 100.05 101.25 99.45
Dec 18, 2024 101.55 1.10 1.10% 100.45 102.15 100.45

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Biomerieux Company profile

About BioMerieux SA

Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The Company also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, BioMerieux SA revenues increased 8% to EUR3.38B. Net income applicable to common stockholders increased 49% to EUR601.1M. Revenues reflect Microbiology segment increase of 12% to EUR1.06B, Molecular Biology segment increase of 5% to EUR1.27B, Europe & Middle East & Africa (EMEA) (Region) segment increase of 10% to EUR1.12B, America segment increase of 5% to EUR1.67B.

Equity composition

9/2017, 3-for-1 stock split (Factor: 3).

Industry: Laboratory Diagnostic & Testing Substances

376, chemin de l'Orme
CRAPONNE
AUVERGNE-RHONE-ALPES 69280
FR

People also watch

Gold

2,703.08 Price
-0.430% 1D Chg, %
Long position overnight fee 0.0056%
Short position overnight fee -0.0138%
Overnight fee time 22:00 (UTC)
Spread 0.60

XRP/USD

3.20 Price
-2.130% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01598

BTC/USD

102,773.35 Price
+3.420% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

ETH/USD

3,356.42 Price
+1.900% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading